- Home
- AARD vs SMHI Comparison
AARD vs SMHI Comparison
Compare AARD & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- SMHI
- Stock Information
- Founded
- AARD 2017
- SMHI 1989
- Country
- AARD United States
- SMHI United States
- Employees
- AARD N/A
- SMHI N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- SMHI Marine Transportation
- Sector
- AARD Health Care
- SMHI Consumer Discretionary
- Exchange
- AARD Nasdaq
- SMHI Nasdaq
- Market Cap
- AARD 154.9M
- SMHI 139.9M
- IPO Year
- AARD 2025
- SMHI N/A
- Fundamental
- Price
- AARD $13.68
- SMHI $5.26
- Analyst Decision
- AARD Strong Buy
- SMHI
- Analyst Count
- AARD 5
- SMHI 0
- Target Price
- AARD $33.00
- SMHI N/A
- AVG Volume (30 Days)
- AARD 84.2K
- SMHI 113.9K
- Earning Date
- AARD 08-14-2025
- SMHI 07-30-2025
- Dividend Yield
- AARD N/A
- SMHI N/A
- EPS Growth
- AARD N/A
- SMHI N/A
- EPS
- AARD N/A
- SMHI N/A
- Revenue
- AARD N/A
- SMHI $264,089,999.00
- Revenue This Year
- AARD N/A
- SMHI N/A
- Revenue Next Year
- AARD N/A
- SMHI $11.59
- P/E Ratio
- AARD N/A
- SMHI N/A
- Revenue Growth
- AARD N/A
- SMHI N/A
- 52 Week Low
- AARD $4.88
- SMHI $3.63
- 52 Week High
- AARD $19.58
- SMHI $14.52
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- SMHI 45.31
- Support Level
- AARD N/A
- SMHI $5.20
- Resistance Level
- AARD N/A
- SMHI $5.59
- Average True Range (ATR)
- AARD 0.00
- SMHI 0.27
- MACD
- AARD 0.00
- SMHI -0.04
- Stochastic Oscillator
- AARD 0.00
- SMHI 18.99
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.